Sulleman Moreea

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin

G. M. Kabir Uddin, D. Shoeb, Susannah Solaiman et al. · Journal of Viral Hepatitis · 2009 · 110 citations

Veterinary Medicine, Health Sciences, Infectious Diseases +14

Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated

Edmond Atallah, Jane I. Grove, Colin Crooks et al. · Journal of Hepatology · 2023 · 59 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

Kathy L. de Graaf, G Lapeyre, Walter Ferlin et al. · Hepatology Communications · 2018 · 47 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

The Diversity and Management of Chronic Hepatitis B Virus Infections in the United Kingdom: A Wake-up Call

Richard S. Tedder, Alison Rodger, Lori Fries et al. · Clinical Infectious Diseases · 2012 · 43 citations · Full text

Medicine, Infectious Diseases, Microbiology +15